Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Yewange Sangmeshwar; Deshpande Renuka; Nikhil Waghmare; Vidyasagar Gali; Shyamlila B. Bavage; Nandkishor B. Bavage

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Authors: Yewange Sangmeshwar, Deshpande Renuka, Nikhil Waghmare, Vidyasagar Gali, Shyamlila B. Bavage, Nandkishor B. Bavage

Unique Paper ID: 149343
Volume: 6
Issue: 12
PageNo: 15-19

Keywords: chloroquine clinical research clinical trials corona virus in COVID-19 disease & medicine hydroxychloroquine malaria nut shell SARS-CoV-2

Abstract:
The desperate search to find effective treatments for coronavirus disease 2019 (COVID-19), 2 generic drugs, used largely by rheumatologists and dermatologists to treat immune-mediated diseases, have entered the spotlight. The antimalarials hydroxychloroquine (HCQ) and chloroquine (CQ) have demonstrated antiviral activity against severe acute respiratory syndromeâ€“coronavirus 2 (SARSâ€“CoV-2) in vitro and in small, poorly controlled or uncontrolled clinical studies (1â€“3). Normally, such research would be deemed hypothesis-generating at best. Here, we try to provide guidance regarding clinical decision making both for patients with COVID-19 and those with immune-mediated conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and strategies to mitigate further harm to these patients.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 6
Issue: 12
PageNo: 15-19

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Available:https://ijirt.org/Article?manuscript=149343

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry